Sunitinib Viatris 12.5 mg

Sunitinib Viatris 12.5 mg is a medicine authorised by Swissmedic under authorisation number 68094. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 March 2021 and the authorisation is valid without a time limit. ATC code L01EX01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68094
  • ATC L01EX01
  • Synthetic medicines
Authorisation data
Authorisation number68094
NameSunitinib Viatris 12.5 mg
Full nameSunitinib Viatris 12.5 mg, Hartkapseln
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EX01
First authorisation29 March 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Sunitinib Viatris 12.5 mg, HartkapselnA29 March 2021
2Sunitinib Viatris 25 mg, HartkapselnA29 March 2021
3Sunitinib Viatris 50 mg, HartkapselnA29 March 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
428Kapsel(n)L01EX0107.16.1.A
528Kapsel(n)L01EX0107.16.1.A
628Kapsel(n)L01EX0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Sunitinib Viatris 12.5 mg authorised in Switzerland?

Yes. Sunitinib Viatris 12.5 mg is authorised by Swissmedic under authorisation number 68094, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Sunitinib Viatris 12.5 mg have?

Sunitinib Viatris 12.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Sunitinib Viatris 12.5 mg?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com